African American men currently have the highest rates of prostate cancer in the United States and the poorest outcomes. New grants from the U.S. Department of Defense and American Cancer Society will fund work by two Roswell Park Comprehensive Cancer Center teams focused on understanding and eliminating prostate cancer health disparities.

A multidisciplinary team led by Roswell Park Comprehensive Cancer Center has identified troponin, a protein that enters the bloodstream only when the heart is damaged, as an early and reliable predictor of myocarditis in cancer patients receiving immunotherapy with immune checkpoint inhibitor (ICI) drugs. Findings of this retrospective study, which have been published in the Journal for ImmunoTherapy of Cancer, suggest that weekly troponin monitoring during the first six weeks of treatment could help physicians detect this rare but potentially fatal side effect of cancer immunotherapy.

With 2021 coming to a close, Roswell Park Comprehensive Cancer Center is proud to celebrate the 128 physicians across 33 specialties named to Buffalo Spree magazine’s Top Doctor’s list for 2022. Each year, the list is compiled through surveys submitted by Western New York physicians.

Since the introduction of electronic cigarettes, or e-cigarettes, to the United States in 2006, intense debate has surrounded the marketing, regulation and use of these nicotine-delivery products. Surprising new research led by Roswell Park Comprehensive Cancer Center has found that adult smokers with no plans to quit are more likely to quit smoking traditional combustible cigarettes if they switch to daily vaping.

Congressman Brian Higgins (NY-26) and Roswell Park CEO Dr. Candace Johnson recently joined a Congressional Cancer Caucus briefing with National Cancer Institute director Dr. Ned Sharpless and other national leaders discussing the National Cancer Act, which was signed into law on December 23, 1971, and efforts to continue making strides in cancer research and treatment.